Access Support Videos

Videos

Advocacy to Reduce the Impact of Drug Shortages on Cancer Care

07/23/2024

Laura Bray, MBA, talks about her experience as a patient advocate with Angels of Change and the key drivers impacting drug shortages.

Laura Bray, MBA, talks about her...

07/23/2024

Journal of Clinical Pathways

Videos

St. Elizabeth’s Innovative Cancer Screening Outreach Model

09/22/2023

Featuring Michael Gieske, MD, and Jamie Ries, RN, BSN

Featuring Michael Gieske, MD, and Jam...

Michael Gieske, MD, and Jamie Ries, RN, BSN, speak about the development of a care delivery model that demonstrates sustainable outreach for cancer screening, with a specific focus on at-risk and underserved patient populations.

Michael Gieske, MD, and Jamie...

09/22/2023

Journal of Clinical Pathways

Videos

Impact of Dose Rounding Bevacizumab and its Biosimilars on Total Cost of Care for OCM Participants

07/26/2023

Featuring Puneeth Indurlal, MD

Featuring Puneeth Indurlal, MD ...

Puneeth Indurlal, MD, discusses the impact of dose rounding that targets bevacizumab and its biosimilars on the total cost of care and drug waste expenditures for Oncology Care Model participants in the US Oncology Network.

Puneeth Indurlal, MD, discusses...

07/26/2023

Journal of Clinical Pathways

Videos

The Impact of Elsevier ClinicalPath Oncology Treatment Pathways on Survival and Cost of Care

07/24/2023

Featuring Monica Schmidt, PhD

In an interview with the Journal of Clinical Pathways, Monica Schmidt, PhD, MPH, discusses her study on the impact of using Elsevier’s ClinicalPath oncology pathways on short-term survival and cost of care from the patient and health system...

In an interview with the Journal...

07/24/2023

Journal of Clinical Pathways

Videos

Study Examines the Association Between Oncologists’ Receipt of Pharmaceutical Industry Payments and Use of Nonrecommended/Low-Value Treatments

07/20/2023

Featuring Aaron P. Mitchell, MD

Featuring Aaron P. Mitchell, MD ...

Aaron P. Mitchell, MD, MPH, discusses his research on the association of pharmaceutical industry payments to oncologists and their increased use of nonrecommended and/or low-value treatment methods.

Aaron P. Mitchell, MD, MPH,...

07/20/2023

Journal of Clinical Pathways

Videos

Health Care Access and Affordability for Adult Immigrant Cancer Survivors

06/26/2023

Featuring Patricia Santos, MD

Patricia Santos, MD, Memorial Sloan Kettering Cancer Center, spoke with the Journal of Clinical Pathways at the ASCO 2023 Annual Meeting about her research on the coverage and affordability of health care access for adult immigrant cancer...

Patricia Santos, MD, Memorial...

06/26/2023

Journal of Clinical Pathways

Conference Coverage

Benefits and Challenges of the Enhancing Oncology Model

06/13/2023

At the ASCO 2023 Annual Meeting, Lalan Wilfong, MD, provided an overview of the Enhancing Oncology Model and how it differs from and improves upon the Oncology Care Model.

At the ASCO 2023 Annual Meeting,...

06/13/2023

Journal of Clinical Pathways

Videos

A Value-based Framework for Drug Cost Support and Funding Programs

05/11/2023

Dr Daniel Virnich, President, The Oncology Institute, discusses his presentation on drug cost support and funding programs for patients with cancer from Oncology at Total Health 2022.

Dr Daniel Virnich, President,...

05/11/2023

Journal of Clinical Pathways

Adria Warren, Partner at Foley & Lardner LLP

Videos

New Developments in the 340B Drug Pricing Program

04/03/2023

Adria Warren, health care transactional partner at Foley & Lardner LLP, spoke with the Journal of Clinical Pathways about new developments in the 340B drug pricing program and provided updates on recent court rulings and cases in process that...

Adria Warren, health care...

04/03/2023

Journal of Clinical Pathways

Videos

Making Clinical Pathways Unique to the Patient Journey

11/14/2022

Lee Fleisher, MD, discusses balancing the need for uniform quality care for all patients with finding the proper pathways for individual patients.

Lee Fleisher, MD, discusses...

11/14/2022

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Access Support Videos

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products